DALLAS, Sept. 3, 2026 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company") today announced that it has received written notification from the New York Stock Exchange ("NYSE") confirming that the Company has regained compliance with the NYSE's continued listing standard under Section 802.01C of the NYSE Listed Company Manual regarding the minimum share price requirement.

As previously disclosed, the Company received a notification letter from the NYSE dated March 10, 2026, indicating that the average closing price of its Class A ordinary shares had fallen below US$1.00 over a consecutive 30-trading-day period. In connection with its efforts to regain compliance, the Company effected a 10-for-1 share consolidation of its Class A ordinary shares and Class B ordinary shares, which became effective on July 20, 2026.

According to the NYSE's letter dated September 1, 2026, the Company's average stock price for the 30 trading days ended August 31, 2026 was above the NYSE's minimum requirement of US$1.00. Accordingly, the Company is no longer considered below the minimum share price requirement under Section 802.01C, and the matter is closed.

About Cango Inc.

Cango Inc. (NYSE: CANG) is a Bitcoin mining company with a vision to establish an integrated, global infrastructure platform capable of powering the future digital economy. The Company's mining operations span across North America, the Middle East, South America, and East Africa.

Since entering the digital asset space in November 2024, Cango has activated pilot projects in both integrated energy solutions and distributed AI computing. In parallel, Cango continues to operate an online international used car export business through AutoCango.com.

For more information, please visit: www.cangoonline.com and follow us on: X and LinkedIn.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Cango may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Cango's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Cango's goal and strategies; Cango's expansion plans; Cango's future business development, financial condition and results of operations; Cango's expectations regarding demand for, and market acceptance of, its solutions and services; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in Cango's filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and Cango does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

SOURCE Cango Inc.

Share this article

Prudential Advisors Welcomes Zachary Karason to Mid America Financial Group

Former U.S. Bancorp and Merrill Lynch advisor joins Prudential Advisors

NEWARK, N.J., Sept. 3, 2026 /PRNewswire/ -- Prudential Advisors, the wealth management arm of Prudential Financial, Inc. (NYSE: PRU), welcomes Zachary Karason, a Cleveland-based financial advisor with more than 12 years of financial services experience. Responsible for over $106 million in total client assets at U.S. Bancorp Advisors, Karason joins Prudential Advisors through the firm's Mid America Financial Group, headquartered in Columbus, Ohio.

"Zach has built a respected wealth management practice, earning the trust of individuals, executives, business owners, and families through personalized advice and lasting relationships," said John Begley, managing director, Prudential Advisors. "We are excited that Zach has joined our firm, where he will have access to an expanded and robust investment platform, enhanced planning resources, and industry-leading technology that will allow him to serve clients more effectively while increasing the efficiency of his practice."

Karason received his bachelor's degree from Northwood University. He began his financial services career at Merrill Lynch, becoming an assistant vice president before joining U.S. Bancorp Advisors as a wealth management advisor.

"I wanted the freedom to run my practice in the way I believe best serves my clients," said Karason. "My approach is grounded in transparency and education to help clients better understand and navigate what can be a complex financial world. With Prudential Advisors' expanded support, innovative technology, and greater flexibility, I can deliver a more personalized client experience and offer objective, customized advice with fewer constraints."

Prudential Advisors provides an open-architecture platform for experienced financial professionals who are looking to grow their businesses, backed by a well-respected national enterprise with the scale to help them succeed in a competitive marketplace.

"I'm thrilled that Zach is joining our growing team in the greater Cleveland market," says Pat Hynes, president of Prudential Advisors. "At Prudential Advisors, he will have all the tools and resources he needs to make a smooth transition and take his practice to the next level. We look forward to helping him thrive."

ABOUT PRUDENTIAL ADVISORS

Prudential Advisors supports the growth and success of more than 3,000 financial advisors across the country, backed by local field leaders and associates in our headquarters. The business enables financial advisors to help their clients build wealth and meet financial goals through personalized advice and comprehensive solutions. For more information, please visit prudential.com/advisors.

ABOUT PRUDENTIAL

Prudential Financial, Inc. (NYSE: PRU), a global financial services leader and premier active global investment manager with approximately $1.6 trillion in assets under management as of June 30, 2026, has operations in the United States, Asia, Europe, and Latin America. Prudential's diverse and talented employees help make lives better and create financial opportunity for more people by expanding access to investing, insurance, and retirement security. Prudential's iconic Rock symbol has stood for strength, stability, expertise, and innovation for over 150 years. For more information, please visit news.prudential.com.

MEDIA CONTACT

Mike Klein

732-742-4032

michael.klein@prudential.com

© 2026 Prudential Financial, Inc. and its related entities. Prudential, the Prudential logo, and the Rock symbol are service marks of Prudential Financial, Inc. and its related entities, registered in many jurisdictions worldwide.

1092773-00001-00

SOURCE Prudential Advisors

Share this article

Silicon Line®, an EverProX® brand, Launches new Ultra-Low-Power SerDes Chipset MSDL™ (MIPI Serial Data Link), Extending 20 Gbps MIPI D-PHY Connectivity to Tens of Meters

New optical/electrical solution aggregates two simultaneous MIPI-DPHY camera streams, at up to 10 Gbps each, over two serialized links while consuming less than 100 mW per link, eliminating bulky cable bundles with optical fiber or differential copper connectivity. Discover more: https://silicon-line.com/msdl

MUNICH, Sept. 3, 2026 /PRNewswire/ -- EverProX Technologies Munich GmbH, under its Silicon Line® brand—a pioneer in ultra-low-power optical and electrical interconnect technology—today announced the launch of "MSDL™ 20G" which is the first product in the new MSDL™ family, an end-to-end interconnect chipset comprising the SL8582x serializer and SL8581x de-serializer. Engineered to overcome the bandwidth, EMI, and reach limitations of traditional MIPI D-PHY signals, the dual-port chipset delivers up to two simultaneous 10 Gbps serialized links for next-generation vision systems.

Breaking Physical Cabling Bottlenecks

As high-resolution multi-camera systems and high-frame-rate displays drive rapidly increasing bandwidth requirements, traditional copper cabling is increasingly constrained by limited reach and susceptibility to electromagnetic interference (EMI). The "MSDL™ 20G" chipset, comprising SL8582x serializer and SL8581x de-serializer resolves this by aggregating multi-stream video over optical fibers or differential copper pairs, extending link distances to tens of meters while eliminating bulky, shielded cable bundles. The highly integrated architecture delivers ultra-low-power consumption in both optical and electrical modes, with total SerDes power well below 100 mW per 10 Gbps link.

Executive Perspective

"Physical AI is changing the way electronic systems are built. We are seeing more and faster cameras, more sensors, and greater intelligence distributed across devices," said Yifeng Liann, CEO and Managing Director of EverProX Technologies Munich GmbH. "As systems get smarter, moving high-bandwidth data between devices reliably and in real time becomes increasingly challenging. Engineers must balance the flexibility to connect across different subsystems, the reliability that mission-critical applications cannot always get from wireless, and the ultra-low power needed to make it all practical. That's the problem the Silicon Line® team set out to solve: making high-bandwidth connectivity more energy-efficient, more reliable, and easier to integrate into the next generation of intelligent systems."

Key Technical Highlights

- Dual-Port Multi-Camera Aggregation: Supports up to two simultaneous transmissions of single- or stereo-camera streams over one or two serialized links, with one transmission per link

- Optical or Copper Connectivity: Integrated VCSEL drivers and TIA enable optical links over tens of meters, while supporting differential copper links up to 2 meters

- Ultra-Low Power: Consumes just 71 mW per optical link and 87 mW per electrical link, excluding the integrated Sideband SerDes:

- Optical Mode: Serializer 17 mW, De-serializer 54 mW (Typical)

- Electrical Mode: Serializer 27 mW, De-serializer 60 mW (Typical)

- Integrated Bidirectional Sideband SerDes: Transports I²C, GPIO, digital audio, SPI/control signals and sensor clocks alongside MIPI data, reducing cable count, connector complexity, and system components.

- Target Applications:

- AR/VR: Enables lighter, more flexible tethering and greater mobility

- Medical Endoscopy: Supports 4K/8K imaging, ultra-low heat generation, and thin optical connectivity

- Industrial Robotics and Machine Vision: Delivers reliable, EMI-immune high-speed vision connectivity in electrically noisy environments

- Defense and UAVs: Provides lightweight, low-power multi-camera connectivity that reduces cable weight and increases battery life

Availability & Ecosystem Support

The MSDL™ 20G (SL8582x&SL8581x) are sampling now with early-access customers in bare die or compact 4×4 mm µBGA-78 packages. Evaluation Kits (EVKs) are available now for link validation. Backed by EverProX's turnkey assembly, customers can transition seamlessly from IC design to mass production. For more information, visit https://www.silicon-line.com/ or contact sales@silicon-line.com.

About EverProX Technologies Munich GmbH and Silicon Line®

Silicon Line® — a brand of EverProX Technologies Munich GmbH — is a leading IC developer of ultra-low-power optical and electrical interconnect solutions for high-speed video and data transmission. Based in Munich, Germany, the Silicon Line® portfolio includes ultra low power MIPI SerDes ICs (from MSDL™ 2G up to MSDL™ 20G), TIA&VCSEL drivers that enable ultra-thin, lightweight, and EMI-immune active optical cables (AOCs) and embedded optical links for VR/AR, medical, industrial, robotics, defense and consumer markets.

Media Contact:

Emre Oralli

Product Marketing Manager 

EverProX Technologies Munich GmbH / Silicon Line® 

Email: emre.Oralli@silicon-line.com

Phone: +49 151 20620735

SOURCE EverProX Technologies Munich GmbH

Share this article

LITEON Announces Strategic Investment in Liquid Cooling Technology Company DCX

Advancing AI Infrastructure Value Chain Through Integrated Power Management and Cooling Technologies

TAIPEI, Sept. 3, 2026 /PRNewswire/ -- LITEON Technology (2301.TW) today announced a strategic investment in DCX POLSKA Sp. z o.o. ("DCX Liquid Cooling Systems"), a Warsaw, Poland-based provider of advanced liquid cooling systems for AI and High-Performance Computing (HPC) data centers. Upon closing of the transaction, LITEON will hold approximately 25% equity ownership in DCX Liquid Cooling Systems with a total transaction value of approximately US$176 million. The investment brings together DCX's deep expertise in liquid cooling technologies, including coolant distribution units (CDUs), facility coolant distribution units (FDUs), cold plates and immersion cooling systems, with LITEON's strengths in AI server power management, rack-level power delivery and 800VDC power architectures. Together, the two companies are positioned to deliver highly integrated power and thermal management solutions for the rapidly evolving AI infrastructure and next-generation high-density computing market.

The accelerating adoption of AI applications is driving unprecedented rack power densities, making liquid cooling a critical enabling technology for future-ready data centers and high-performance computing. Founded in 2019 and headquartered in Warsaw, Poland, DCX Liquid Cooling Systems has established itself as a leading innovator in direct-to-chip and immersion liquid cooling, with advanced design and integration capabilities in liquid cooling infrastructure for data centers, offering a complete portfolio ranging from enterprise-level coolant distribution units (600kW–2.6MW) to hyperscale-class facility coolant distribution units (up to 16MW), as well as cold plates, rack manifolds and modular data center systems. Through this strategic partnership, LITEON and DCX Liquid Cooling Systems will expand collaboration across product development, engineering innovation, manufacturing scale-up, and global go-to-market initiatives. The companies will jointly develop integrated power-and-cooling platforms designed to address the increasing performance and efficiency demands of the hyperscale data center customers worldwide.

"AI has become a key force reshaping industries, and data center infrastructure is a critical foundation for unlocking AI's full potential," said Tom Soong, Chairman of LITEON. "As we continue to invest in advanced technologies, this strategic investment further strengthens LITEON's position across the AI data center value chain. Through this partnership, we look forward to advancing innovation and creating new possibilities in the rapidly expanding AI market. LITEON will continue to engage with global partners that possess deep technological expertise and strong strategic synergies, strengthening cross-domain technology integration through both strategic investments and long-term collaboration. By bringing together complementary capabilities across the AI data center value chain, we aim to advance a more resilient and comprehensive AI infrastructure ecosystem, expand system-level solution capabilities, and create sustainable competitive advantages for the next era of computing."

Maciek Szadkowski, Chief Technology Officer at DCX Liquid Cooling Systems, added, "LITEON's deep expertise in power electronics, global manufacturing scale, and long-standing hyperscaler relationships make it a highly strategic partner for DCX. We regard this alliance as both an obligation and a commitment - to deliver the best, state-of-the-art technology for our strategic partner and for the world-class customers. This partnership will accelerate our global growth and combine the strengths of both companies to deliver broad next-generation data center infrastructure solutions."

"LITEON is a partner whose global scale and engineering heritage we deeply respect, and we are proud that our liquid cooling technology will help to shape what they bring to the world's data centers. Together we can offer operators a single integrated solution, ready for the next generation of AI computing platforms and beyond." said Tomasz Buk, Chief Executive Officer at DCX Liquid Cooling Systems.

SOURCE LITEON Technology

Share this article

В преддверии IFA 2026 лидеры отрасли обсудили будущее энергетической независимости для европейского бизнеса на панельной дискуссии The Economist

При участии директора по стратегии EcoFlow Ника Чена (Nick Chen) и руководителей CEER, Elia Group и Equinix в панельной дискуссии The Economist «Гибкость как принцип: энергетическая устойчивость бизнеса» (Flexible by Design: Energy Resilience for Business) обсуждалось, как гибкость энергопотребления и интеллектуальные технологии стимулируют повышение конкурентоспособности европейской промышленности.

БЕРЛИН, 3 сентября 2026 г. /PRNewswire/ -- Стремительный рост числа центров обработки данных для искусственного интеллекта и электромобилей доводит европейские энергосистемы до предела их возможностей, в результате чего обеспечение энергетической устойчивости быстро превратилось из задачи коммунального хозяйства в стратегический приоритет высшего руководства компаний на всем континенте. В преддверии выставки IFA Berlin 2026 (4–8 сентября) The Economist Enterprise и EcoFlow сегодня объявили о выходе в эфир панельной дискуссии руководителей «Гибкость как принцип: энергетическая устойчивость бизнеса» (Flexible by Design: Energy Resilience for Business).

В дискуссии приняли участие ведущие представители сферы регулирования энергетики, эксплуатации электросетей, цифровой инфраструктуры и промышленности, чтобы обсудить одну из наиболее острых проблем европейского бизнеса — преодоление ограничений электросетевой инфраструктуры и непредсказуемости затрат на электроэнергию.

В условиях беспрецедентной волатильности цен и многолетних очередей на подключение к электросетям, EcoFlow использует опыт эксплуатации более 10 млн своих устройств и взаимодействия с 5 млн пользователей по всему миру для расширения деятельности в сегментах малого бизнеса и корпоративных клиентов. Перенося в коммерческий сегмент проверенную в массовой эксплуатации архитектуру своих потребительских решений — модульное оборудование, автоматизированную оптимизацию энергопотребления с учетом динамических тарифов и программное обеспечение на базе искусственного интеллекта — EcoFlow предоставляет коммерческим предприятиям возможность быстро и экономически эффективно повысить свою энергетическую независимость.

«Малый и средний бизнес сталкивается с той же волатильностью цен на энергию и такими же высокими затратами, что и бытовые потребители, — заявил директор по стратегии EcoFlow Ник Чен (Nick Chen). — Обеспечивая энергией миллионы домов во всем мире, мы убедились, что для массового внедрения чистой энергетики необходимы три составляющие: предельная простота, модульная масштабируемость и интеллектуальная автоматизация с помощью программного обеспечения. Выводя нашу проверенную технологическую платформу для потребительского сегмента и интеллектуальные программные решения на коммерческий рынок, мы предоставляем предприятиям инструменты, необходимые им для простого управления сложными энергетическими потребностями, снижения операционных расходов и обеспечения надежности энергоснабжения».

Основные аспекты панельной дискуссии

- Трансформация энергетического рынка и стратегия: как колебания цен на энергоносители, ограничения электросетевой инфраструктуры и периоды отрицательных оптовых цен меняют инвестиционные решения компаний и условия развития бизнеса в Европе.

- Экономически эффективное обеспечение энергетической устойчивости: практические подходы, позволяющие предприятиям защитить свою деятельность от перебоев в электроснабжении и резких скачков цен без чрезмерных капитальных затрат.

- Преодоление ограничений электросетевой инфраструктуры: как очереди на подключение к электросетям угрожают промышленному росту и каким образом гибкие соглашения о подключении и механизмы управления спросом позволяют оперативно снизить остроту проблемы.

- Распределенные энергетические ресурсы как элемент инфраструктуры: роль небольших распределенных систем накопления энергии, солнечной генерации и программного обеспечения для управления энергопотреблением, работающих совместно с магистральными сетями для балансирования спроса и предложения.

- Перспективы на период до 2030 года: как происходящие сегодня изменения в регулировании и внедрение новых технологий будут определять структуру рынка электроэнергии и конкурентоспособность Европы в течение следующего десятилетия.

Участники панельной дискуссии

- Ник Чен (Nick Chen) – директор по стратегии, EcoFlow

- Брам Клайс (Bram Claeys) – генеральный секретарь Совета европейских регуляторов энергетики (Council of European Energy Regulators, CEER)

- Джеймс Маттис-Доннадьё (James Matthys-Donnadieu) – директор по работе с клиентами, рынкам и системам, Elia Group

- Эулалия Фло (Eulalia Flo) – вице-президент по росту и развивающимся рынкам в Европе, Equinix

- Филип Корнелл (Phillip Cornell) (модератор) – старший советник по вопросам энергетики и устойчивого развития, Economist Enterprise

Посмотрите запись дискуссии и встретьтесь с EcoFlow на IFA 2026

- Посмотреть дискуссию: полная запись панельной дискуссии доступна для просмотра по запросу на портале The Economist Events Portal.

- Посетите стенд EcoFlow на выставке IFA 2026: EcoFlow приглашает отраслевых партнеров, представителей СМИ и посетителей ознакомиться с новейшими энергетическими экосистемами для жилого и коммерческого секторов на выставке IFA Berlin 2026, которая пройдет с 4 по 8 сентября в выставочном комплексе Messe Berlin (зал 3.2).

О компании EcoFlow

Компания EcoFlow, основанная в 2017 году, является лидером в области интеллектуальных решений для накопления энергии в домашних условиях, предоставляя миллионам пользователей возможность самостоятельно управлять энергоснабжением своего дома и за его пределами. Наше видение — обеспечить энергией новый мир, устремленный в будущее, основанный на технологиях и бережном отношении к окружающей среде. С первого дня наша миссия состоит в предоставлении интеллектуальных и экологически чистых энергетических решений для отдельных людей, семей и общества в целом. Мы были, остаемся и всегда будем надежным энергетическим партнером для пользователей во всем мире. Для получения дополнительной информации обращайтесь на веб-сайт https://www.ecoflow.com

Share this article

Iconic Excellence premieres Sept. 18, commemorating the 85th anniversary year of Dr. Drew's

historic appointment as the first medical director of the Red Cross Blood Program.

WASHINGTON, Sept. 3, 2026 /PRNewswire/ -- The American Red Cross and the NAACP will premiere Iconic Excellence: The Legacy of Dr. Charles R. Drew, a new documentary honoring the father of blood banking, Sept. 18 on the American Red Cross YouTube channel. The short film highlights Drew's revolutionary breakthroughs in blood plasma preservation, which saved hundreds of thousands of lives during World War II and pioneered modern methods for collecting, preserving and distributing blood.

A LEGACY OF EXCELLENCE

Produced by the Red Cross in collaboration with Drew's family, the NAACP and Omega Psi Phi Fraternity Inc., the documentary offers an intimate portrait of Drew's drive and leadership, tracing his path from his childhood in Washington, D.C., to global prominence as a Black surgeon, educator and champion for inclusivity in medicine. Beyond the science, the film reveals a family man guided by his principles: a scientific stance against the U.S. military's blood segregation policy and a mantra on excellence he instilled in generations of Black surgeons.

"Dr. Drew is an unsung hero of World War II," said NAACP President and CEO Derrick Johnson. "His innovation made it possible for many American soldiers to come home to their families."

In 1944, while blood segregation was still official policy, the NAACP awarded Dr. Drew the Spingarn Medal for his work in blood plasma research and blood banking. "The Spingarn Medal still today is considered the highest honor that can be bestowed on an African American in this country," said Johnson.

Dr. Drew was 45 when he died in a car accident in 1950. His daughters and grandchildren have spent decades honoring and preserving his legacy ever since. In Iconic Excellence, together on camera for the first time, his family gives that account in full, including answers to questions that have surrounded his legacy: whether he received blood products himself in the hours after the accident, and why he left the Red Cross, long attributed to Drew protesting the blood segregation policy.

"My father's work in training other Black surgeons was uppermost in his mind at the time of his death because he trained a small legion of Black surgeons, who then trained another group of Black surgeons, who then trained another group...whose color wasn't the most important thing," said Dr. Charlene Drew Jarvis, Drew's middle daughter. "It was: are they trained? Do they know? Do they understand? Who are they going to serve?"

CARRYING THE LEGACY FORWARD

Drew's commitment to mobilizing communities to improve health care carries forward today through organizations that host blood drives in support of the Red Cross Sickle Cell Initiative. Working with community partners, the Red Cross has nearly doubled the number of annual blood donors who are Black or African American, an increase of more than 89% since the Sickle Cell Initiative launched in 2021. To date, more than 445,770 donors who are Black or African American have given blood to support patients living with sickle cell disease, with more than 188,000 of them being first-time blood donors.

"Dr. Drew understood something we continue to see every day at the Red Cross: when you meet people where they are and invite them to be part of the mission, they respond," said Chris Hrouda, president of American Red Cross Biomedical Services. "Many first-time blood donors roll up a sleeve because someone helped them understand the impact a single donation can have on a patient in need. That was Dr. Drew's approach 85 years ago, and it remains a powerful way lives are saved today."

Iconic Excellence premieres during Sickle Cell Awareness Month in September. Organizations and community groups can register to host a screening, a blood drive, or both by visiting RedCrossBlood.org/IconicExcellence. To schedule a blood donation appointment, visit RedCrossBlood.org/OurBlood, use the Blood Donor App or call 1-800-RED CROSS (1-800-733-2767).

ABOUT THE FILM

Iconic Excellence tells Dr. Drew's story through his own family and the voices of the NAACP, Omega Psi Phi Fraternity Inc. and the American Red Cross. On-camera voices include Bebe Drew Price, Dr. Charlene Drew Jarvis, Sylvia Drew Ivie, Dr. Kelly Price Noble, Ernie Drew Jarvis; Derrick Johnson, president and CEO of the NAACP; Ricky Lewis, 42nd International President of Omega Psi Phi Fraternity Inc.; Chris Hrouda, president of American Red Cross Biomedical Services; and Dr. Yvette Miller, American Red Cross executive medical officer. Journalist DeMarco Morgan narrates. The film was written and executive produced by Tiffany Taylor and directed by Brad Zerivitz, with cover art by Melissa Koby.

About the American Red Cross:

The American Red Cross shelters, feeds and provides comfort to victims of disasters; supplies about 40% of the nation's blood; teaches skills that save lives; distributes international humanitarian aid; and supports veterans, military members and their families. The Red Cross is a nonprofit organization that depends on volunteers and the generosity of the American public to deliver its mission. For more information, please visit redcross.org or CruzRojaAmericana.org, or follow us on social media.

About the NAACP:

The NAACP advocates, agitates, and litigates for the civil rights due to Black America. Our legacy is built on the foundation of grassroots activism by the biggest civil rights pioneers of the 20th century and is sustained by 21st century activists. From classrooms and courtrooms to city halls and Congress, our network of members across the country works to secure the social and political power that will end race-based discrimination. That work is rooted in racial equity, civic engagement, and supportive policies and institutions for all marginalized people. We are committed to a world without racism where Black people enjoy equitable opportunities in thriving communities.

NOTE: The Legal Defense Fund – also referred to as the NAACP-LDF – was founded in 1940 as a part of the NAACP, but now operates as a completely separate entity.

SOURCE American Red Cross

Share this article

BEIJING and FLORENCE, Italy, Sept. 3, 2026 /PRNewswire/ -- Gan & Lee Pharmaceuticals ("Gan & Lee"; stock code: 603087.SH) announced that it has entered into an exclusive license agreement with the multinational biopharmaceutical company The Menarini Group ("Menarini"). Under the agreement, the parties will collaborate on the registration and commercialization of Gan & Lee's independently developed glucagon-like peptide-1 receptor agonist (GLP-1 RA), bofanglutide (development code: GZR18), under development for the treatment of adults with obesity or overweight, administered once every two weeks.

Under the agreement, Gan & Lee is eligible to receive an upfront payment of EUR 62million, milestone payments totaling up to EUR 664million, and double-digit royalties on net sales in the licensed territory. The aggregate potential deal value is up to EUR 726million, excluding royalties.

Menarini will be responsible for regulatory submissions and commercialization in the licensed territory in a total of 39 countries: the 27 Member States of the European Union; the United Kingdom, Switzerland, Norway, Iceland, Liechtenstein and Balkans countries.

This agreement marks a strategic milestone in Menarini's mission to expand its footprint in the metabolic space, a critical area that affects an increasingly broad patients' population in need.

Bofanglutide is a China Class 1 investigational drug independently developed by Gan & Lee. Its key feature is a once-every-two-weeks subcutaneous dosing regimen, which reduces administration frequency 50% compared with once-weekly GLP-1 RAs. The pivotal Phase 3 study in China and the Phase 2 study in the United States for weight management in adults with obesity or overweight both met their primary endpoints, demonstrating weight-loss efficacy and consistent tolerability profile with other GLP-1RA class therapies.

Gan & Lee regards bofanglutide as a flagship product of its innovative pipeline and is advancing its registration and commercialization through global partnerships. Menarini will represent a strategic partner to expand Bofanglutide's presence in highly regulated markets, accelerating the development potential of such strategic asset on a global footprint.

Looking ahead, Gan & Lee is actively advancing the global development plan for bofanglutide and intends to initiate a global Phase 3 clinical development program to support registration in Europe and other highly regulated markets. The company will continue to expand its global footprint through innovative R&D and high-quality products.

Commenting on the agreement, Dr. Wei Chen, Chairman and CEO of Gan & Lee said, "This partnership establishes a pivotal pathway for bofanglutide's entry into the European market and marks another milestone in Gan & Lee's transformation—from a leader in insulin to a global innovator in metabolic disease. By integrating Gan & Lee's expertise in clinical development, manufacturing, and supply with Menarini's strength in Regulatory strategy and commercial execution, we aim to bring an alternative therapy to millions of people living with obesity or overweight across the Territories."

Elcin Barker Ergun, Group CEO of Menarini, said, "Clinical study results for bofanglutide so far have demonstrated weight reduction, secondary metabolic benefits, and a safety profile consistent with expectations for this class, while its once-every-two-weeks dosing regimen offers an opportunity for differentiation. We look forward to closely working with Gan & Lee for successful completion of further pivotal studies to bring this potential new option to patients across all our Territories, leveraging on Menarini's established capabilities and know-how."

From a global strategy perspective, this agreement represents a transformative milestone for both companies. For Gan & Lee, it marks an extended geographical expansion for its innovative pipeline, further strengthening its presence in highly regulated markets. For Menarini, the partnership is a critical step in its mission to expand its footprint in the metabolic space and accelerate its journey towards innovation in Primary and Specialty Care.

This license agreement represents another important milestone in the continued advancement of Gan & Lee's global strategy. As a leading European pharmaceutical company with deep market expertise and an established commercial network, Menarini is an ideal partner for bofanglutide in Europe. Through close collaboration, Gan & Lee and Menarini aim to advance this differentiated investigational medicine efficiently and broaden access for patients.

About Bofanglutide

Bofanglutide (GZR18) is an investigational, long-acting glucagon-like peptide-1 receptor agonist (GLP-1 RA) independently developed by Gan & Lee Pharmaceuticals. It is currently in clinical development under a once-every-two-weeks administration schedule for weight management in adults living with obesity or overweight, type 2 diabetes mellitus (T2DM), and other metabolic conditions. Bofanglutide is an investigational compound; its safety and efficacy have not been established or authorized by the European Medicines Agency (EMA) or other health authorities, and it is not approved for commercial distribution.

About Gan & Lee

Gan & Lee Pharmaceuticals is a high-tech biopharmaceutical company and the first in China to master industrial-scale manufacturing technologies for recombinant insulin analogs. The Company has established a comprehensive biologic research and development pipeline. Looking forward, Gan & Lee is committed to achieving comprehensive coverage across the diabetes and obesity treatment landscape and further enhancing its competitive position in this therapeutic area. The Company will also actively pursue the development of innovative chemical drugs and biologics, with a strategic focus on metabolic diseases, cardiovascular diseases, immunology diseases, and other therapeutic areas. www.ganlee.com

About The Menarini Group

The Menarini Group, with headquarters in Florence, is present in 140 countries worldwide to date, with €4.88 billion in consolidated turnover and more than 17,000 employees. Menarini's products are present in the most important treatment areas, including those of cardiometabolic, oncology, gastroenterology, diabetology, pneumology, and anti-inflammatory/analgesic products. Through its commitment in R&D and high quality manufacturing activities, Menarini continuously contributes to patients' health worldwide, maintaining the highest quality standards. www.menarini.com

(Translations: in the event of any discrepancy, the English language version prevails)

SOURCE Menarini Industrie Farmaceutiche Riunite

Share this article

Las nuevas instalaciones mejoran la eficiencia, agilizan la entrega y optimizan la experiencia del cliente

MAHWAH, Nueva Jersey, 3 de septiembre de 2026 /PRNewswire-HISPANIC PR WIRE/ -- Mindray North America, líder mundial en innovación sanitaria en los ámbitos de cuidados perioperatorios, diagnóstico por imagen y cuidados intensivos, ha anunciado hoy la inauguración oficial de sus nuevas instalaciones de almacén ampliadas en Mahwah, Nueva Jersey. El proyecto comenzó con una ceremonia de inicio de obras el 17 de junio de 2025, con la que se añadieron 46,314 pies cuadrados a las instalaciones existentes, lo que elevó la superficie total a 80,979 pies cuadrados. Este compromiso refleja la confianza de Mindray en su crecimiento a largo plazo y su dedicación a prestar servicio a los profesionales sanitarios de toda Norteamérica con mayor rapidez, eficiencia y fiabilidad.

Al agrupar las operaciones externas en una única sede centralizada, Mindray optimizará la logística, mejorará la gestión de los pedidos y reducirá las complicaciones relacionadas con los envíos para los clientes.

"Dado que los sistemas sanitarios siguen sometidos a la presión de satisfacer una demanda cada vez mayor con menos recursos, nos enorgullece celebrar la finalización de una inversión multimillonaria que refuerza nuestra capacidad para apoyar a los profesionales sanitarios, garantizándoles un acceso fiable a las tecnologías que necesitan", afirmó Wayne Quinn, presidente de Mindray North America. "Estas instalaciones ampliadas reflejan nuestro compromiso con la creación de una cadena de suministro resiliente y con visión de futuro que aumente la eficiencia operativa, reduzca los plazos de entrega y ayude a nuestros clientes a centrarse en ofrecer una atención de calidad a los pacientes".

Esta expansión se produce, además, en un momento crucial de la trayectoria de crecimiento de Mindray. La empresa está ampliando activamente su cartera hacia nuevas categorías de productos, incluido el lanzamiento de su nueva línea de respiradores, y tiene previstas varias ampliaciones de la gama en los próximos 18 meses. Esta diversificación estratégica pone de manifiesto el firme compromiso de Mindray con la satisfacción de las necesidades cambiantes del sector sanitario. Las nuevas instalaciones amplias ofrecen la capacidad, la infraestructura necesaria y la tecnología operativa avanzada, lo que garantiza que los clientes dispongan de un acceso oportuno a una gama más amplia de soluciones a medida que la cartera sigue creciendo.

"Esta ampliación supone un importante paso adelante para nuestras operaciones, ya que nos proporciona una mayor capacidad, un flujo de trabajo mejorado y prestaciones de última generación diseñadas para cumplir con los más altos estándares de seguridad", afirmó Derek Scott, director de operaciones de Mindray North America.

La consolidación también contribuye a los objetivos de sostenibilidad de Mindray. Al combinar operaciones que antes estaban dispersas, la empresa reduce el transporte por carretera, agrupa los envíos de los clientes y disminuye su huella de carbono global. El proyecto refleja además la cultura de Mindray, centrada en las personas, a través de un patio de nuevo diseño y un paisajismo mejorado, lo que crea un entorno acogedor para los empleados, los socios y los visitantes.

Con la finalización de esta ampliación, Mindray North America se encuentra en una posición idónea para apoyar a los profesionales sanitarios con soluciones innovadoras y accesibles, respaldadas por una infraestructura más sólida y una cadena de suministro de gran capacidad de respuesta.

Acerca de Mindray

Mindray es una empresa líder en el desarrollo, la fabricación y el suministro de soluciones y tecnologías de dispositivos médicos que se utilizan en centros sanitarios de todo el mundo. En Mindray, nos esforzamos por cumplir con los estándares más exigentes posibles porque creemos que todo el mundo merece tener acceso a una asistencia sanitaria de calidad. Como resultado, llevamos más de 30 años impulsando el avance de las tecnologías médicas, ofreciendo soluciones sólidas y de primera categoría centradas en nuestros clientes y diseñadas para dar respuesta a sus principales dificultades. Mindray ofrece soluciones innovadoras, de vanguardia y accesibles para el ámbito perioperatorio, el diagnóstico por imagen y los cuidados intensivos, lo que permite a los profesionales sanitarios proporcionar una atención de la máxima calidad, tanto ahora como en el futuro. Para obtener más información, visite www.mindray.com/na

FUENTE Mindray North America

Share this article

Riester-Nachfolger: quirion und Vanguard starten strategische Partnerschaft fürs Altersvorsorgedepot

Berlin (ots)

Das gesetzliche Standarddepot wird mit zwei Vanguard-ETFs umgesetzt. Im Fokus stehen niedrige, transparente Kosten und eine breite Marktabdeckung.

- Start: 1. Januar 2027

- Zwei Vanguard-ETFs: ein weltweit streuender Aktien-ETF und ein Anleihe-ETF

- Persönliche Kundenbetreuung und Finanz-KI quirion.Ai

Zum 1. Januar 2027 startet das staatlich geförderte Altersvorsorgedepot, der Nachfolger der Riester-Rente. Für das gesetzlich vorgesehene Standarddepot, das besonders einfache Basisprodukt der Reform, gehen der digitale Vermögensverwalter quirion und Vanguard eine strategische Partnerschaft ein. quirion, dreifacher Testsieger bei Stiftung Warentest, setzt das Standardprodukt mit zwei breit diversifizierten und kostengünstigen Vanguard-ETFs um.

Der Markt für die neue geförderte Altersvorsorge ist groß. Bereits im Mai 2026, als die Reform verabschiedet wurde, konnten sich in einer quirion-Umfrage 52 Prozent der Förderberechtigten vorstellen, ein Altersvorsorgedepot zu eröffnen. Mit näher rückendem Start und wachsender Bekanntheit dürfte dieser Anteil inzwischen eher höher liegen. Branchenschätzungen gehen für 2027 von rund 4,5 Millionen Vertragsabschlüssen und einem jährlichen Sparvolumen von rund 7 Milliarden Euro aus. Hinzu kommen rund 16 Millionen bestehende Riester-Verträge, für die ab 2027 ein Wechsel möglich wird.

Die Erwartungen der Menschen sind dabei klar. In der Umfrage stehen verständliche, transparente Produktinformationen (59 Prozent) und niedrige Gebühren (55 Prozent) an erster Stelle, noch vor einer attraktiven Rendite (48 Prozent). Zugleich ist die Skepsis groß: Fast die Hälfte (49 Prozent) vermutet bei vermeintlich kostenlosen Angeboten einen Haken, weil ein zertifiziertes Depot nichts darüber aussagt, welche Fonds darin stecken und was sie kosten. Bei quirion gibt es diesen Haken nicht: Beide ETFs sind klar benannt und günstig, und der digitale Vermögensverwalter wird mit einem kostenfreien Angebot an den Start gehen.

Zwei Häuser, eine Haltung

quirion und Vanguard verbindet dieselbe Grundüberzeugung: Niedrige, transparente Kosten sind die Basis einer erfolgreichen Altersvorsorge. Vanguard hat das kostengünstige Indexinvestment für Privatanlegerinnen und -anleger populär gemacht. Weil das Unternehmen genossenschaftlich aufgestellt ist, sind niedrige Kosten dort Teil der Struktur. quirion und die Muttergesellschaft Quirin Privatbank stehen für dieselbe Haltung: Sie verzichten konsequent auf Provisionen und arbeiten allein im Interesse ihrer Kundinnen und Kunden.

"Der deutsche Vorsorgemarkt ist von hoher Komplexität und unterschiedlichen Interessen geprägt. Das kann es Menschen schwer machen, die für sie richtige Vorsorgeentscheidung zu treffen. Mit Vanguard haben wir einen Partner, der dasselbe Ziel verfolgt wie wir: eine einfache und gute Geldanlage für möglichst viele Menschen. Wir wollen mit dieser Partnerschaft zeigen, wie ein Altersvorsorgedepot aussehen kann, das Fehlanreize und Fehlentscheidungen vermeidet."

- Matthias Lamberti, Chief Product & Innovation Officer, quirion

"Seit Vanguards Gründung verfolgen wir das Ziel, die Chancen der Kapitalmärkte für möglichst viele Anlegerinnen und Anleger zugänglich zu machen. Das neue Altersvorsorgedepot kann für Deutschland ein wichtiger Schritt in diese Richtung sein. Mit quirion verbindet uns die Überzeugung, dass eine gute Altersvorsorge vor allem einfach, breit diversifiziert und kosteneffizient sein sollte. Deshalb freuen wir uns, gemeinsam eine Lösung zu unterstützen, die die Interessen der Sparerinnen und Sparer in den Mittelpunkt stellt."

- Fabian Behnke, Leiter Strategic Accounts, Vanguard

Worauf es bei den Kosten ankommt

Die Erfahrungen mit der Riester-Rente haben gezeigt, wie stark hohe Kosten die Rendite über die Jahre schmälern können. Der gesetzliche Kostendeckel von einem Prozent für das Standardprodukt ist ein wichtiger Fortschritt. Für quirion und Vanguard ist er allerdings eine Obergrenze und kein Qualitätsmaßstab. quirion hält ihn für deutlich zu hoch. Wie groß der Effekt niedriger Kosten über eine lange Ansparzeit sein kann, zeigt ein Rechenbeispiel im Anhang.

Was Sparerinnen und Sparer ab 2027 von quirion erwarten können

- Das Standardprodukt besteht aus zwei Vanguard-ETFs: dem Vanguard FTSE Global All-Cap (weltweit gestreute Aktien, TER 0,07 %) und dem Vanguard Global Aggregate Bond EUR Hedged (währungsgesicherte Anleihen, TER 0,08 %)

- Breite Diversifikation

- Automatisches Rebalancing für ein dauerhaft passendes Risiko-Rendite-Profil

- Persönliche Kundenbetreuung und Unterstützung durch die Finanz-KI quirion.Ai

- Keine Abschlussgebühren, keine Provisionen, transparente Kosten

Ergänzend ist ein Riester-Check auf Basis von quirion.Ai geplant, mit dem Riester-Sparerinnen und -Sparer prüfen können, ob sich ein Wechsel ins Altersvorsorgedepot lohnt.

Über quirion

quirion ist mit über 3 Mrd. Euro verwaltetem Vermögen einer der führenden digitalen Vermögensverwalter in Deutschland und dreifacher Testsieger bei Stiftung Warentest (2018, 2021, 2026). Als Tochter der Quirin Privatbank bietet quirion professionell gemanagte ETF-Portfolios für einen kostengünstigen, breit diversifizierten Zugang zu den internationalen Kapitalmärkten. Ab 2027 ergänzt das geförderte Altersvorsorgedepot das Angebot. quirion wurde 2013 von Karl Matthäus Schmidt gegründet.

Über Vanguard

Vanguard wurde 1975 gegründet und zählt heute zu den weltweit führenden Vermögensverwaltern. Das Unternehmen bietet hochwertige Anlagefonds und Investmentlösungen mit einem klaren Ziel: Anleger fair zu behandeln und ihnen die bestmöglichen Voraussetzungen für langfristigen Anlageerfolg zu bieten. Weltweit verwaltet Vanguard Vermögen von 13,3 Billionen US-Dollar im Auftrag seiner Anleger. (Quelle: Vanguard, Stand: 30. Juni 2026).

Anhang 1 - Rechenbeispiel: Wie der Kostenunterschied wirkt

Bei einem Eigenbeitrag von 200 EUR monatlich erhält ein Sparer inklusive maximaler staatlicher Grundzulage insgesamt 245 EUR monatlichen Sparbetrag. Bei einer angenommenen Bruttomarktrendite von 7 % p. a. vor Kosten über 30 Jahre ergibt sich:

- 0 % Kosten (Nettorendite 7,0 % p. a.) -> Endkapital ca. 288.000 EUR

- 0,5 % Kosten (Nettorendite 6,5 % p. a.) -> Endkapital ca. 263.000 EUR

- 1,0 % Kosten (Nettorendite 6,0 % p. a.) -> Endkapital ca. 240.000 EUR

- Differenz gegenüber dem kostenfreien Fall: rund 48.000 EUR (bei 1 % Kosten) bzw. rund 25.000 EUR (bei 0,5 % Kosten)

Hinweis: Das Beispiel dient nur der Veranschaulichung des Kosteneffekts, nicht als Renditeprognose.

Anhang 2 - Checkliste: Worauf Sparer beim Anbietervergleich achten sollten

- TER der eingesetzten ETFs: Laufende Fondskosten sind ein zentraler Renditefaktor über lange Laufzeiten.

- Kosten des Depots: Verwaltungs- und Servicekosten wirken sich direkt auf die Nettorendite aus.

- Marktnähe: Je näher ein Produkt am breiten Markt investiert, desto besser kommt die Marktentwicklung beim Anleger an.

- Auto-Rebalancing: Erhält das ursprüngliche Risiko-Rendite-Profil des Portfolios.

- Kundensupport: Gute Erreichbarkeit und verständliche Unterstützung sind bei Vorsorgethemen entscheidend.

- Unabhängige Testergebnisse: Bewertungen etwa von Stiftung Warentest schaffen zusätzliche Orientierung.

Pressekontakt:

Dirk Althoff

Unternehmenskommunikation

quirion AG

Kurfürstendamm 119

10711 Berlin

Telefon: +49 (0)30 89021-358

E-Mail: dirk.althoff@quirion.de

Original-Content von: quirion AG, übermittelt durch news aktuell

Farbe Blau Creative Communication GmbH

Wachstum braucht Orientierung: FARBE BLAU entwickelt mit der Unternehmerfamilie Rolf Doetsch die Dachmarke RD UNIQUE PLACES

Inning am Ammersee (ots)

Mit dem Wachstum von Unternehmen entstehen neue Standorte, Angebote und Geschäftsfelder. Gleichzeitig wird es anspruchsvoller, ihre Zugehörigkeit und ihren gemeinsamen Ursprung nach außen sichtbar zu machen. Vor dieser strategischen Herausforderung stand die Unternehmerfamilie Rolf Doetsch, deren Hospitality-Unternehmen in den vergangenen Jahren weit über PURS Fine Hotels & Restaurants hinausgewachsen sind. Gemeinsam mit FARBE BLAU entstand daraus die Dachmarke RD UNIQUE PLACES.

Was als kommunikative Begleitung von PURS Fine Hotels & Restaurants begann, entwickelte sich zu einer grundlegenden strategischen Fragestellung: Wie lassen sich unterschiedliche Hotels, Restaurants und Erlebnisorte unter einem gemeinsamen Dach zusammenführen, ohne ihre Eigenständigkeit zu verlieren? Die Antwort darauf liefert die neue Markenarchitektur.

"Unsere Häuser sind sehr unterschiedlich, doch sie verbindet derselbe Anspruch: besondere Orte zu schaffen, die Menschen berühren und in Erinnerung bleiben. RD UNIQUE PLACES gibt dieser gemeinsamen Haltung einen einheitlichen Rahmen und schafft eine starke Grundlage für unsere weitere Entwicklung", sagt Phillip Doetsch, Prokurist von PURS Fine Hotels & Restaurants.

Markenarchitektur gewinnt für wachsende Unternehmen an Bedeutung

Eine klare Markenarchitektur schafft Orientierung, stärkt Wiedererkennbarkeit und ermöglicht eine konsistente Kommunikation über unterschiedliche Geschäftsfelder und Kanäle hinweg. Dabei geht es nicht darum, bestehende Marken zu ersetzen, sondern ihre Zusammengehörigkeit sichtbar zu machen und gleichzeitig ihre jeweilige Stärke zu bewahren.

"Wachstum schafft neue Angebote, Zielgruppen und Berührungspunkte. Eine klare Markenarchitektur wird dabei zum strategischen Erfolgsfaktor und bringt diese Entwicklungen in einen nachvollziehbaren Zusammenhang. Die neue Dachmarke bildet einen gemeinsamen Rahmen und macht die übergeordneten Werte sichtbar", sagt Sinja Grimme, Gründerin und Geschäftsführerin der Kommunikationsagentur FARBE BLAU.

Eine gemeinsame Identität für außergewöhnliche Orte

RD UNIQUE PLACES steht für Authentizität, kulturelle Verbundenheit, Gastlichkeit und den Anspruch, einzigartige Orte mit nachhaltiger Wirkung zu schaffen. Das PURS bleibt mit seiner besonderen Architektur, seinem Designanspruch und dem Sternerestaurant der Leuchtturm der Gruppe und für viele nationale wie internationale Gäste der erste Berührungspunkt mit der Marke.

"Viele Unternehmen investieren erfolgreich in neue Standorte, Konzepte und Geschäftsfelder. Unternehmerisches Wachstum mit einer klaren Marken-Identität zu verbinden, ist die Kür und die Voraussetzung für langfristige und erfolgreiche Kundenbeziehungen", so Sinja Grimme.

Über FARBE BLAU

FARBE BLAU ist eine inhabergeführte Agentur für Markenstrategie, Unternehmenskommunikation, Public Relations und Positionierung von Unternehmerpersönlichkeiten mit Sitz am Ammersee bei München. Die Agentur begleitet Unternehmen, Unternehmerfamilien, Eigentümer und Führungspersönlichkeiten bei Wachstums-, Veränderungs- und Positionierungsprozessen. Zu den Schwerpunkten zählen die Entwicklung von Markenstrategien und Markenarchitekturen sowie die kommunikative Begleitung von Transformationen und Wachstumsprozessen. Darüber hinaus verantwortet FARBE BLAU das eigene Thought-Leadership-Format Vision Circle, eine regelmäßig stattfindende Dialogplattform zu Zukunftsfragen an der Schnittstelle von Wirtschaft, Technologie und Gesellschaft.

Pressekontakt:

Clarissa Klingelhöller

FARBE BLAU GmbH

Landsberger Straße 57

82266 Inning am Ammersee

Deutschland

clarissa.klingelhoeller@farbeblau.de

Original-Content von: Farbe Blau Creative Communication GmbH, übermittelt durch news aktuell